| Invasive Malignant Neoplasm studied in …STUDIED_INderived200 of 1,820show all (up to 200) |
|---|
| → studied in | NCT02345265Phase 2 · active not recruiting Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02446600Phase 3 · active not recruiting Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02502266Phase 2/Phase 3 · active not recruiting Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02883062Phase 2 · active not recruiting Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03348631Phase 2 · active not recruiting Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03598257Phase 2 · active not recruiting Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Bladder Giant Cell Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564377Phase 2 · recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05987241Phase 2/Phase 3 · recruiting Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06890338Phase 2 · recruiting A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer. · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061964Phase 2 · recruiting Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07504588Phase 2 · recruiting Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Platinum-Sensitive Ovarian High Grade Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705035Phase 1 · recruiting DBC-664 in Adult Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05867251Phase 1/Phase 2 · recruiting Study of AVZO-021 in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05956093NA · active not recruiting 68Ga-FAPI PET/CT in the Staging of High-Grade Epithelial Ovarian Cancers: A Pilot Study · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06586957Phase 1 · recruiting A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06619236Phase 3 · active not recruiting Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06770582Phase 2 · recruiting Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06833073Phase 2 · recruiting A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06919965Phase 3 · recruiting A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02945579NA · recruiting Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03564340Phase 1/Phase 2 · recruiting Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Low-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981119recruiting Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05316155Phase 1/Phase 2 · active not recruiting Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172478Phase 2 · recruiting A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06211764Phase 3 · active not recruiting A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06319820Phase 3 · recruiting A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06369610Phase 2 · active not recruiting Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06877676approved for marketing Pre-Approval Expanded Access Study for TAR-200 Treating Physician Use · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07309445recruiting A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02860000Phase 2 · completed Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05412225Phase 1 · recruiting A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06290687Phase 2 · withdrawn Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06605404recruiting Pan-tumor MRD Study · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07800507Phase 1/Phase 2 · not yet recruiting Trop2-Targeted Near-Infrared Fluorescence Imaging-Guided Precise Resection of Non-Muscle Invasive Bladder Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03387553early Phase 1 · completed HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07025369Phase 2 · recruiting Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07708753Phase 3 · recruiting A Study of SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05276973Phase 1 · active not recruiting Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07265739Phase 2 · not yet recruiting Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04084730Phase 2 · recruiting Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma of No Special Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04506554Phase 2 · active not recruiting A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05920798Phase 1/Phase 2 · active not recruiting Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05983432Phase 1 · recruiting Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06529822Phase 1 · recruiting Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07495124Phase 2 · recruiting IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07804056Phase 3 · recruiting A Study to Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832227Phase 2 · not yet recruiting Imlunestrant/Abemaciclib/Selinexor in Ovarian and Endometrial · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Ovarian Low Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01334021Phase 2 · active not recruiting Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04053842Phase 2 · completed Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04614051Phase 1 · terminated A Phase 1 Study of Cellgram-DC in Patients With Advanced or Recurrent Epithelial Ovarian Cancer · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985565NA · active not recruiting Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07650240Phase 2 · recruiting Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04152499Phase 1/Phase 2 · active not recruiting Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05003752Phase 1/Phase 2 · active not recruiting Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05415527NA · completed Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05616650Phase 2 · recruiting Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05665738NA · recruiting Two-fraction HDR Monotherapy for Localized Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06205316Phase 3 · active not recruiting SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06733363Phase 2 · recruiting A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07332351Phase 2 · not yet recruiting Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667335Phase 1/Phase 2 · recruiting Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Invasive Bladder Giant Cell Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819045NA · completed Self-Acceptance and Supportive Accountability for Active Living Among Adults Receiving Chemotherapy · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07825181not yet recruiting Homologous Recombination Repair Deficiency (HRD) Testing in Newly Diagnosed Advanced-stage Epithelial Ovarian Cancer in Italy · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02194387NA · active not recruiting Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05796375Phase 2 · recruiting Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07489287Phase 1 · recruiting GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07718854Phase 2 · recruiting Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Ovarian Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821879recruiting Routine Shallow-coverage Whole Genome Sequencing Testing of Liquid-based Cervical Smears for the Early Diagnosis of Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07822373Phase 2 · not yet recruiting A Phase 2 Study Evaluating Bladder Preservation With Enfortumab Vedotin Plus Pembrolizumab in Patients With Muscle-Invasive Urothelial Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02453620Phase 1 · active not recruiting Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04286386withdrawn Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538663Phase 3 · active not recruiting Intravesical BCG vs GEMDOCE in NMIBC · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06412510Phase 1/Phase 2 · active not recruiting Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06915025Phase 3 · recruiting Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07303894Phase 2 · recruiting A Study of Isoquercetin in People With Ovarian Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07429487NA · recruiting Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07702292Phase 2 · recruiting [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07777848Phase 2 · not yet recruiting A Study to Evaluate the Efficacy and Safety of RAG-01 as Monotherapy and in Combination With Chemotherapy in Patients With Non-muscle Invasive Bladder Cancer (NMIBC). · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821177early Phase 1 · active not recruiting Bladder Preservation or Cystectomy for MIBC · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01012817Phase 1/Phase 2 · active not recruiting Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02703623Phase 2 · active not recruiting Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02812420early Phase 1 · active not recruiting Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03070886Phase 2/Phase 3 · active not recruiting Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03077841Phase 2/Phase 3 · suspended Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03359954Phase 2 · active not recruiting Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04266249Phase 2 · active not recruiting CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04575935Phase 3 · recruiting Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05014139Phase 1 · terminated A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059444recruiting ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05710328Phase 2 · active not recruiting Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06503614Phase 2 · recruiting A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer · condition mapped PROBABILISTIC · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07772869NA · recruiting Uterine Lavage to Detect Ovarian Cancer Risk · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | BRCA Hereditary Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07817173NA · not yet recruiting Feasibility of HISA During TURBT for NMIBC · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01807065Phase 2 · completed Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04633239Phase 1 · recruiting Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04905082NA · active not recruiting HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05081609Phase 1/Phase 2 · active not recruiting A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06964009Phase 1 · recruiting DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06990061NA · recruiting Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 Study · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07238023NA · active not recruiting Promoting Active Living Among People With Advanced Cancer · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101775Phase 2 · active not recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Clear Cell Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Bladder Plasmacytoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05946213Phase 3 · recruiting Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07811271Phase 3 · not yet recruiting Efficacy and Safety of BG-C9074 With Bevacizumab Compared With Bevacizumab in Adults With Ovarian, Fallopian Tube, or Primary Peritoneal Cancers · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595892Phase 2 · active not recruiting Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03317392Phase 1/Phase 2 · active not recruiting Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03606967Phase 2 · recruiting Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04001829Phase 2 · active not recruiting Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04030507NA · active not recruiting Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04592237Phase 2 · active not recruiting Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Prostate Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07225270Phase 3 · recruiting Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Sensitive Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07604766Phase 3 · recruiting An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04585958Phase 1 · recruiting Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01366144Phase 1 · active not recruiting Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02208375Phase 1 · active not recruiting mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04315233Phase 1 · terminated Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327608NA · recruiting Time Restricted Eating for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05950464Phase 1 · recruiting Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Ovarian Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06470750completed Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP) · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06515613Phase 1 · recruiting A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07755436Phase 1 · recruiting Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer. · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07801898Phase 2 · not yet recruiting Neoadjuvant Endocrine Therapy Combined With Chemotherapy in ER-positive, HER2-negative Stage I-III Breast Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02750826Phase 3 · active not recruiting Breast Cancer WEight Loss Study (BWEL Study) · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03762759Phase 2 · active not recruiting Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05334069recruiting Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05837767NA · recruiting A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma of No Special Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06931340Phase 3 · recruiting Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995898NA · recruiting The Vanguard Study: Testing a New Way to Screen for Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07200830Phase 3 · recruiting Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00086567completed Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05710380NA · recruiting MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07564141Phase 3 · recruiting Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Sensitive Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07791732Phase 3 · not yet recruiting A Study of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab as Maintenance Therapy in Second-Line Platinum-Sensitive Recurrent Ovarian Cancer (REJOICE-Ovarian03) · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07798479completed Age and Bladder Cancer Outcomes After BCG Treatment: A Multicenter Study · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02954874Phase 3 · active not recruiting Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05726292Phase 2 · recruiting A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06654336Phase 2 · recruiting Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC) · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07466498Phase 2 · not yet recruiting Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Castration-Sensitive Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00601900Phase 3 · completed Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01081262Phase 3 · active not recruiting Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01272037Phase 3 · active not recruiting Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02142803Phase 1 · active not recruiting TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Clear Cell Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02839707Phase 2/Phase 3 · active not recruiting Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03371719Phase 2 · active not recruiting Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03775265Phase 3 · active not recruiting Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04677816Phase 2 · recruiting Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06982222Phase 1 · withdrawn Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04878094Phase 3 · active not recruiting A Study of Intra-operative Imaging in Women With Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06492070Phase 2 · recruiting Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07790939early Phase 1 · not yet recruiting 89Zr-DFO-Mirvetuximab PET/CT Imaging for Companion Diagnosis and Response Evaluation in Ovarian Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03204123Phase 2 · active not recruiting PSMA PET Imaging of Recurrent Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03442556Phase 2 · terminated Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04034927Phase 2 · active not recruiting Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04329494Phase 1 · recruiting PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05281471Phase 3 · recruiting Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03067181Phase 3 · recruiting Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Ovarian Choriocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04851119Phase 1/Phase 2 · recruiting Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06022822Phase 2 · recruiting Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07579195Phase 1/Phase 2 · recruiting Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02068794Phase 1/Phase 2 · active not recruiting MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Malignant Ovarian Brenner Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04019327Phase 1/Phase 2 · terminated A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05979298Phase 2 · completed Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781956NA · not yet recruiting Home-Based Supportive Care Program for NMIBC Patients Receiving Intravesical Perfusion: Construction and Preliminary Application · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04147494early Phase 1 · active not recruiting Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04310826NA · active not recruiting Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554367Phase 2 · active not recruiting Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Low Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06738654NA · recruiting Application of Single-Port Robot-Assisted Breast-Conserving Surgery Via Axillary Approach for Breast Cancer. · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07480356Phase 3 · recruiting Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04673448Phase 1 · active not recruiting Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | BRCA Hereditary Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04902872Phase 1/Phase 2 · completed Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04945642NA · recruiting High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05269381Phase 1/Phase 2 · recruiting Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Lobular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06315491Phase 2 · terminated A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995053NA · active not recruiting Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07191717Phase 2 · recruiting Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07776171Phase 2 · not yet recruiting Trastuzumab Rezetecan and Carboplatin ± Bevacizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-sensitive Recurrent Ovarian Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Sensitive Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01791478Phase 1 · completed BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma of No Special Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03604315Phase 1 · recruiting Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04423211Phase 3 · recruiting Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04550494Phase 2 · active not recruiting Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05545150Phase 2 · completed Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05919108Phase 2 · recruiting Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Lobular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07772882Phase 1 · not yet recruiting Study of Supplemental Arginine With Chemotherapy and Immunotherapy in Platinum Resistant Ovarian, Fallopian Tube, and Peritoneal Cancer · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096054Phase 1 · completed A Phase I Trial of LY3143921 Hydrate in Solid Tumours · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07097142Phase 3 · recruiting Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07470853Phase 1 · recruiting A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors. · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01266642Phase 2 · active not recruiting Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04134260Phase 3 · active not recruiting Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04513717Phase 3 · active not recruiting Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04840589Phase 1 · suspended Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors · condition mapped CURATED_BROADER · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05050084Phase 3 · active not recruiting Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05053152Phase 2 · active not recruiting Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05225363Phase 1 · recruiting Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05340673Phase 1 · active not recruiting Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05415709early Phase 1 · active not recruiting Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05776758Phase 3 · active not recruiting Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06792552Phase 1 · recruiting A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors · condition mapped ALIAS · 1,820 trials mapped (688 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06957691Phase 2 · recruiting Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy · condition mapped ONTOLOGY_EXACT · 1,820 trials mapped (688 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |